The Austrian National Public Health Institute is pleased to annouce to be part of the ASCERTAIN consortium: The affordability of newly approved innovative health technologies (IHTs) is challenging in…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
ASCERTAIN: New Horizon Europe research project to improve the affordability and sustainability of innovative health technologies
Oslo Medicines Initiative: technical reports on innovation and transparency
The Oslo Medicines Initiative (OMI) has commissioned a series of technical reports to review and analyze the relevant evidence and provide policy considerations. Two reports were authored by an WHO…
Redesignation as WHO Collaborating Centre until 2026
We proudly announce that the Pharmacoeconomics Department at GÖG has been re-designated as WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies for another four years until…